Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
Clinical trial NCT00085462 · COMPLETED
Trial details
- NCT number
- NCT00085462
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2007-05-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.